
Twist Bioscience (NASDAQ: TWST)
Twist Bioscience Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Twist Bioscience Company Info
Twist works with biopharma companies to use its DNA writing technology to create and screen DNA libraries that can express antibodies the drug companies could be interested in.
News & Analysis
Top Biotech ETFs to Buy Now
Here are the five best biotech ETFs to invest in right now.
Why Shares of Twist Bioscience Are Up Friday
The company reported improved financials in the third quarter.
2 Cathie Wood Growth Stocks That Could Make You Richer
These two biotechs could be winning plays for aggressive investors.
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
Cathie Wood is loading up on these biotech stocks.
Why Twist Bioscience Stock Is Sinking Today
Investors didn't like the synthetic DNA maker's guidance.
Why Twist Bioscience Stock Is Crashing This Week
Investors were spooked by a short-seller's allegations.
Why Shares of Twist Bioscience Fell 19.92% on Tuesday
A negative report by a short-seller drove the biotech's shares downward.
3 Monster Stocks in the Making
These companies are small now. But they have massive long-term growth prospects.
Valuation
Earnings Transcripts
Twist Bioscience Corporation (TWST) Q4 2021 Earnings Call Transcript
TWST earnings call for the period ending September 30, 2021.
Twist Bioscience Corporation (TWST) Q3 2021 Earnings Call Transcript
TWST earnings call for the period ending June 30, 2021.
Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript
TWST earnings call for the period ending March 31, 2021.
Twist Bioscience Corp (TWST) Q1 2021 Earnings Call Transcript
TWST earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.